Snowden Capital Advisors LLC Novartis Ag Transaction History

Snowden Capital Advisors LLC

  • $3.12 Billion
  • Q4 2024

A detailed history of Snowden Capital Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 13,099 shares of NVS stock, worth $1.47 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,099
Previous 13,832 5.3%
Holding current value
$1.47 Million
Previous $1.59 Million 19.87%
% of portfolio
0.04%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $70,939 - $85,892
-733 Reduced 5.3%
13,099 $1.27 Million
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $266,704 - $303,796
-2,513 Reduced 15.37%
13,832 $1.59 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $75,999 - $88,150
821 Added 5.29%
16,345 $1.74 Million
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $44,014 - $50,113
462 Added 3.07%
15,524 $1.5 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $105,464 - $116,060
1,143 Added 8.21%
15,062 $1.52 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $129,969 - $144,238
-1,372 Reduced 8.97%
13,919 $1.42 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $98,996 - $112,253
-1,070 Reduced 6.54%
15,291 $1.54 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $40,975 - $47,518
-512 Reduced 3.03%
16,361 $1.51 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $54,773 - $67,077
-725 Reduced 4.12%
16,873 $1.53 Million
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $322,240 - $376,875
-4,319 Reduced 19.71%
17,598 $1.34 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $141,071 - $164,250
-1,752 Reduced 7.4%
21,917 $1.85 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $1.63 Million - $1.84 Million
20,307 Added 604.02%
23,669 $2.08 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $267,951 - $296,293
3,362 New
3,362 $294,000
Q3 2021

Feb 05, 2024
BUY
$81.78 - $95.14 $1.11 Million - $1.29 Million
13,611 Added 97.79%
27,530 $2.25 Billion
Q2 2021

Jan 08, 2024
BUY
$85.24 - $94.15 $1.24 Million - $1.37 Million
14,598 Added 116.75%
27,102 $2.47 Billion
Q1 2021

Jan 08, 2024
BUY
$83.5 - $98.47 $551,684 - $650,591
6,607 Added 112.04%
12,504 $1.07 Billion
Q4 2020

Jan 08, 2024
BUY
$78.07 - $94.43 $224,373 - $271,391
2,874 Added 95.07%
5,897 $557 Million
Q3 2020

Jan 08, 2024
SELL
$82.14 - $91.0 $15,113 - $16,744
-184 Reduced 5.74%
3,023 $263 Million
Q2 2020

Jan 08, 2024
SELL
$80.93 - $91.1 $10,197 - $11,478
-126 Reduced 3.78%
3,207 $280 Million
Q1 2020

Jan 08, 2024
SELL
$70.67 - $99.01 $2,120 - $2,970
-30 Reduced 0.89%
3,333 $275 Million
Q4 2019

Jan 30, 2024
SELL
$84.35 - $95.37 $168 - $190
-2 Reduced 0.06%
3,363 $318 Million
Q4 2019

Jan 08, 2024
SELL
$84.35 - $95.37 $168 - $190
-2 Reduced 0.06%
3,363 $318 Million
Q3 2019

Jan 30, 2024
SELL
$85.54 - $94.26 $27,714 - $30,540
-324 Reduced 8.78%
3,365 $292 Million
Q3 2019

Jan 08, 2024
SELL
$85.54 - $94.26 $1.08 Million - $1.19 Million
-12,583 Reduced 78.9%
3,365 $292 Million
Q2 2019

Jan 30, 2024
SELL
$75.4 - $92.8 $771,342 - $949,344
-10,230 Reduced 73.5%
3,689 $337 Million
Q2 2019

Jan 08, 2024
BUY
$75.4 - $92.8 $923,574 - $1.14 Million
12,249 Added 331.14%
15,948 $338 Million
Q1 2019

Jan 08, 2024
BUY
$75.32 - $86.15 $16,871 - $19,297
224 Added 6.45%
3,699 $356 Million
Q4 2018

Jan 08, 2024
BUY
$73.66 - $82.02 $60,253 - $67,092
818 Added 30.79%
3,475 $298 Million
Q3 2018

Jan 08, 2024
SELL
$66.94 - $77.43 $753,878 - $872,016
-11,262 Reduced 80.91%
2,657 $229 Million

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email